CEO: Ron Cohen

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.


Key numbers

Market Capitalization:77328300
Shares Outstanding: 48030000
Float: 47184575.940000005
Next Earning Date:2020-02-13
TTm EPS: -6.9265
TTm Dividend Rate:
200 days moving average:7.17
50 days moving average: 2.31
One day percent Change: -7.1



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,